The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials.
- DOI
- 10.1177/20420188251383064
- Published
- 2025
- Container
- Therapeutic advances in endocrinology and metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/20420188251383064,
title = {The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials.},
author = {Hoteit BH and Kotaich J and Ftouni H and Hazime F and Safawi A and Masri R and Marwani M},
year = {2025},
journal = {Therapeutic advances in endocrinology and metabolism},
doi = {10.1177/20420188251383064},
url = {https://doi.org/10.1177/20420188251383064}
}RIS
TY - JOUR TI - The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials. AU - Hoteit BH AU - Kotaich J AU - Ftouni H AU - Hazime F AU - Safawi A AU - Masri R AU - Marwani M PY - 2025 JO - Therapeutic advances in endocrinology and metabolism DO - 10.1177/20420188251383064 UR - https://doi.org/10.1177/20420188251383064 ER -
APA
BH, H., J, K., H, F., F, H., A, S., R, M., & M, M. (2025). The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials.. Therapeutic advances in endocrinology and metabolism. https://doi.org/10.1177/20420188251383064
Source records
- pubmed · retrieved 2026-09-25T09:29:41.516Z